Bioenergetic homeostasis decides neuroprotection or neurotoxicity induced by volatile anesthetics: A uniform mechanism of dual effects

Medical Hypotheses

Volumn 77, Issue 2, 2011, Pages 223-229

  Zhang, Jun ^a   Zhou, Wei ^a   Qiao, Hui ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANESTHETIC AGENT; BETA SECRETASE; CYCLOSPORIN A; DEOXYGLUCOSE; ISOFLURANE; SEVOFLURANE; TRICARBOXYLIC ACID; VOLATILE AGENT;

APOPTOSIS; ARTICLE; BIOENERGY; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL TYPE; CONCENTRATION (PARAMETERS); ELECTRON TRANSPORT; ENERGY METABOLISM; ENZYME SYNTHESIS; GLYCOLYSIS; HOMEOSTASIS; HUMAN; HYPOTHESIS; MITOCHONDRION; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION;

ADENOSINE TRIPHOSPHATE; ANESTHETICS, INHALATION; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; ENERGY METABOLISM; GLYCOLYSIS; HOMEOSTASIS; HUMANS; MODELS, NEUROLOGICAL; NEUROGENESIS; NEUROPROTECTIVE AGENTS; REACTIVE OXYGEN SPECIES; VOLATILE ORGANIC COMPOUNDS;

ANIMALIA;

EID: 79960644030     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.04.018     Document Type: Article

References (96)

1. Matchett G.A., Allard M.W., Martin R.D., Zhang J.H. Neuroprotective effect of volatile anesthetic agents: molecular mechanisms. Neurol Res 2009, 31:128-134.
2. Baranov D., Bickler P.E., Crosby G.J., et al. Consensus statement: first international workshop on anesthetics and Alzheimer's disease. Anesth Analg 2009, 108:1627-1630.
3. Wei H., Liang G., Yang H., et al. The common inhalational anesthetic isoflurane induces apoptosis via activation of inositol 1,4,5-trisphosphate receptors. Anesthesiology 2008, 108:251-260.
4. Zhang Y., Dong Y., Wu X., et al. The mitochondrial pathway of anesthetic isoflurane-induced apoptosis. J Biol Chem 2010, 285:4025-4037.
5. Jevtovic-Todorovic V., Hartman R.E., Izumi Y., et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003, 23:876-882.
6. Palanisamy A., Baxter M.G., Keel P.K., Xie Z., Crosby G., Culley D.J. Rats exposed to isoflurane in utero during early gestation are behaviorally abnormal as adults. Anesthesiology 2011, 114:521-528.
7. Shulman R.G., Hyder F., Rothman D.L. Baseline brain energy supports the state of consciousness. Proc Natl Acad Sci USA 2009, 106:11096-11101.
8. Du F., Zhu X., Zhang Y., et al. Tightly coupled brain activity and cerebral ATP metabolic rate. Proc Natl Acad Sci USA 2008, 105:6409-6414.
9. Kalenka A., Hinkelbein J., Feldmann R.E., Kuschinsky W., Waschke K.F., Maurer M.H. The effects of sevoflurane anesthesia on rat brain proteins: a proteomic time-course analysis. Anesth Analg 2007, 104:1129-1135.
10. Arrell D.K., Elliott S.T., Kane L.A., et al. Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ Res 2006, 99:706-714.
11. Sullivan P.G., Brown M.R. Mitochondrial aging and dysfunction in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:407-410.
12. Falk M.J., Kayser E.B., Morgan P.G., Sedensky M.M. Mitochondrial complex I function modulates volatile anesthetic sensitivity in C. elegans. Curr Biol 2006, 16:1641-1645.
13. Kayser E.B., Morgan P.G., Sedensky M.M. Mitochondrial complex I function affects halothane sensitivity in Caenorhabditis elegans. Anesthesiology 2004, 101:365-372.
14. Morgan P.G., Hoppel C.L., Sedensky M.M. Mitochondrial defects and anesthetic sensitivity. Anesthesiology 2002, 96:1268-1270.
15. Bains R., Moe M.C., Larsen G.A., Berg-Johnsen J., Vinje M.L. Volatile anaesthetics depolarize neural mitochondria by inhibition of the electron transport chain. Acta Anaesthesiol Scand 2006, 50:572-579.
16. Hanley P.J., Ray J., Brandt U., Daut J. Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol 2002, 544.3:687-693.
17. Ludwig L.M., Tanaka K., Eells J.T., et al. Preconditioning by isoflurane is mediated by reactive oxygen species generated from mitochondrial electron transport chain complex III. Anesth Analg 2004, 99:1308-1315.
18. Haorah J., Ramirez S.H., Floreani N., Gorantla S., Morsey B., Persidsky Y. Mechanism of alcohol-induced oxidative stress and neuronal injury. Free Radic Biol Med 2008, 45:1542-1550.
19. Fujimoto K., Bosnjak Z.J., Kwok W.M. Isoflurane induced facilitation of the cardiac sarcolemmal KATP channel. Anesthesiology 2002, 97:57-65.
20. Kwok W., Martinelli A.T., Fujimoto K., Suzuki A., Stadnicka A., Bosnjak Z.J. Differential modulation of the cardiac adenosine triphosphate-sensitive potassium channel by isoflurane and halothane. Anesthesiology 2002, 97:50-56.
21. Wang J., Meng F., Cottrell J.E., Kass I.S. The differential effects of volatile anesthetics on electrophysiological and biochemical changes during and recovery after hypoxia in rat hippocampal slice CA1 pyramidal cells. Neuroscience 2006, 140:957-967.
22. Sherer T.B., Kim J.H., Betarbet R., Greenamyre J.T. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 2003, 179:9-16.
23. Gerlach M., Riederer P., Przuntek H., Youdim M.B. MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur J Pharmacol 1991, 208:273-286.
24. Beal M.F., Brouillet E., Jenkins B., Henshaw R., Rosen B., Hyman B.T. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem 1993, 61:1147-1150.
25. Brouillet E., Jenkins B.G., Hyman B.T., et al. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neurochem 1993, 60:356-359.
26. Sipos I., Tretter L., Adam-Vizi V. Quantitative relationship between inhibition of respiratory complexes and formation of reactive oxygen species in isolated nerve terminals. J Neurochem 2003, 84:112-118.
27. Tretter L., Adam-Vizi V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J Neurosci 2000, 20:8972-8979.
28. Huang H.M., Ou H.C., Xu H., Chen H.L., Fowler C., Gibson G.E. Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death. J Neurosci Res 2003, 74:309-317.
29. Li Q.F., Zhu Y.S., Jiang H. Isoflurane preconditioning activates HIF-1alpha, iNOS and Erk1/2 and protects against oxygen-glucose deprivation neuronal injury. Brain Res 2008, 1245(1245):26-35.
30. Gray J.J., Bickler P.E., Fahlman C.S., Zhan X., Schuyler J.A. Isoflurane neuroprotection in hypoxic hippocampal slice cultures involves increases in intracellular Ca2+ and mitogen-activated protein kinases. Anesthesiology 2005, 102:606-615.
31. Pastorino J.G., Hoek J.B., Shulga N. Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res 2005, 65:10545-10554.
32. Miyamoto S., Murphy A.N., Brown J.H. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ 2007, 15:521-529.
33. Treberg J.R., MacCormack T.J., Lewis J.M., Almeida-Val V.M., Val A.L., Driedzic W.R. Intracellular glucose and binding of hexokinase and phosphofructokinase to particulate fractions increase under hypoxia in heart of the amazonian armored catfish (Liposarcus pardalis). Physiol Biochem Zool 2007, 80:542-550.
34. Zuurbier C.J., Keijzers P.J.M., Koeman A., Van Wezel H.B., Hollmann M.W. Anesthesia's effects on plasma glucose and insulin and cardiac hexokinase at similar hemodynamics and without major surgical stress in fed rats. Anesth Analg 2008, 106:135-142.
35. Molliex S., Crestani B., Dureuil B., Rolland C., Aubier M., Desmonts J.M. Differential effects of isoflurane and i.v. anaesthetic agents on metabolism of alveolar type II cells. Br J Anaesth 1999, 82:767-769.
36. Carles M., Dellamonica J., Roux J., et al. Sevoflurane but not propofol increases interstitial glycolysis metabolites availability during tourniquet-induced ischaemia-reperfusion. Br J Anaesth 2008, 100:29-35.
37. Zapp M., Kofke W.A., Davis D.W. Comparison of the effects of volatile anesthetics in varying concentrations on brain energy metabolism with brain ischemia in rats. Neurochem Res 1992, 17:301-305.
38. Loepke A.W., McCann J.C., Kurth C.D., McAuliffe J.J. The physiologic effects of isoflurane anesthesia in neonatal mice. Anesth Analg 2006, 102:75-80.
39. Rozet I., Tontisirin N., Vavilala M.S., Treggiari M.M., Lee L.A., Lam A.M. Prolonged propofol anesthesia is not associated with an increase in blood lactate. Anesth Analg 2009, 109:1105-1110.
40. Horn T., Klein J. Lactate levels in the brain are elevated upon exposure to volatile anesthetics: a microdialysis study. Neurochem Int 2010, 57:940-947.
41. Boutros A., Wang J., Capuano C. Isoflurane and halothane increase adenosine triphosphate preservation, but do not provide additive recovery of function after ischemia, in preconditioned rat hearts. Anesthesiology 1997, 86:109-117.
42. Thomas S., Prins M.L., Samii M., Hovda D.A. Cerebral metabolic response to traumatic brain injury sustained early in development: a 2-deoxy-d-glucose autoradiographic study. J Neurotrauma 2000, 17:649-665.
43. Oertel M.F., Schwedler M., Stein M., et al. Cerebral energy failure after subarachnoid hemorrhage: the role of relative hyperglycolysis. J Clin Neurosci 2007, 14:948-954.
44. Kindler C.H., Eilers H., Donohoe P., Ozer S., Bickler P.E. Volatile anesthetics increase intracellular calcium in cerebrocortical and hippocampal neurons. Anesthesiology 1999, 90:1137-1145.
45. Wei H., Kang B., Wei W., et al. Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Res 2005, 1037:139-147.
46. Kuum M., Kaasik A., Joubert F., Ventura-Clapier R., Veksler V. Energetic state is a strong regulator of sarcoplasmic reticulum Ca2+ loss in cardiac muscle: different efficiencies of different energy sources. Cardiovasc Res 2009, 83:89-96.
47. Blanck T.J., Peterson C.V., Baroody B., Tegazzin V., Lou J. Halothane, enflurane, and isoflurane stimulate calcium leakage from rabbit sarcoplasmic reticulum. Anesthesiology 1992, 76:813-821.
48. Csordás G., Hajnóczky G. SR/ER-mitochondrial local communication: calcium and ROS. Biochim Biophys Acta 2009, 1787:1352-1362.
49. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., Sheu S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004, 287:C817-C833.
50. Bickler P.E., Zhan X., Fahlman C.S. Isoflurane preconditions hippocampal neurons against oxygen-glucose deprivation: role of intracellular Ca2+ and mitogen-activated protein kinase signaling. Anesthesiology 2005, 103:532-539.
51. Cárdenas C., Miller R.A., Smith I., Bui T., et al. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 2010, 142:270-283.
52. Balaban R.S. The role of Ca(2+) signaling in the coordination of mitochondrial ATP production with cardiac work. Biochim Biophys Acta 2009, 1787:1334-1341.
53. Xu C., Bailly-Maitre B., Reed J.C. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 2005, 115:656-664.
54. Istaphanous G.K., Howard J., Nan X., et al. Comparison of the neuroapoptotic properties of equipotent anesthetic concentrations of desflurane, isoflurane, or sevoflurane in neonatal mice. Anesthesiology 2011, 114:578-587.
55. Yang H., Liang G., Hawkins B.J., Madesh M., Pierwola A., Wei H. Inhalational anesthetics induce cell damage by disruption of intracellular calcium homeostasis with different potencies. Anesthesiology 2008, 109:243-250.
56. Liang G., Ward C., Peng J., Zhao Y., Huang B., Wei H. Isoflurane causes greater neurodegeneration than an equivalent exposure of sevoflurane in the developing brain of neonatal mice. Anesthesiology 2010, 112:1325-1334.
57. Wang Q.J., Li K.Z., Yao S.L., Li Z.H., Liu S.S. Different effects of isoflurane and sevoflurane on cytotoxicity. Chin Med J (Engl) 2008, 121:341-346.
58. Sedlic F., Pravdic D., Ljubkovic M., Marinovic J., Stadnicka A., Bosnjak Z.J. Differences in production of reactive oxygen species and mitochondrial uncoupling as events in the preconditioning signaling cascade between desflurane and sevoflurane. Anesth Analg 2009, 109:405-411.
59. Zhang B., Dong Y., Zhang G., et al. The inhalation anesthetic desflurane induces caspase activation and increases amyloid beta-protein levels under hypoxic conditions. J Biol Chem 2008, 283:11866-11875.
60. Dong Y., Zhang G., Zhang B., et al. The common inhalational anesthetic sevoflurane induces apoptosis and increases beta-amyloid protein levels. Arch Neurol 2009, 66:620-631.
61. Gasparini L., Racchi M., Benussi L., et al. Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells. Neurosci Lett 1997, 231:113-117.
62. Velliquette R.A., O'Connor T., Vassar R. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice. Possible early events in Alzheimer's disease pathogenesis. J Neurosci 2005, 25:10874-10883.
63. Xie Z., Dong Y., Maeda U., et al. The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. J Neurosci 2007, 27:1247-1254.
64. Xie Z., Culley D.J., Dong Y., et al. The common inhalation anesthetic isoflurane induces caspase activation and increases amyloid beta-protein level in vivo. Ann Neurol 2008, 64:618-627.
65. Lu Y., Wu X., Dong Y., Xu Z., Zhang Y., Xie Z. Anesthetic sevoflurane causes neurotoxicity differently in neonatal naïve and Alzheimer disease transgenic mice. Anesthesiology 2010, 112:1404-1416.
66. Ferreira I.L., Resende R., Ferreiro E., Rego A.C., Pereira C.F. Multiple defects in energy metabolism in Alzheimer's disease. Curr Drug Targets 2010, 11:1193-1206.
67. Eckenhoff R.G., Johansson J.S., Wei H., et al. Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology 2004, 101:703-709.
68. Mandal P.K., Fodale V. Isoflurane and desflurane at clinically relevant concentrations induce amyloid beta-peptide oligomerization: an NMR study. Biochem Biophys Res Commun 2009, 379:716-720.
69. Biebuyck J.F., Lund P., Krebs H.A. The effects of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) on glycolysis and biosynthetic processes of the isolated perfused rat liver. Biochem J 1972, 128:711-720.
70. Bedirli N., Ofluoglu E., Kerem M., et al. Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model. Anesth Analg 2008, 106:830-837.
71. Li Q., Yu W., Zhou M., et al. Isoflurane preserves energy balance in isolated hepatocytes during in vitro anoxia/reoxygenation. World J Gastroenterol 2005, 11:3920-3924.
72. Da-Silva W.S., Gomez-Puyou A., Gomez-Puyou M.T., et al. Mitochondrial bound hexokinase activity as a preventive antioxidant defense: steady-state ADP formation as a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria. J Biol Chem 2004, 279:39846-39855.
73. Molliex S., Crestani B., Dureuil B., et al. Effects of halothane on surfactant biosynthesis by rat alveolar type II cells in primary culture. Anesthesiology 1994, 81:668-676.
74. Riess M.L., Eells J.T., Kevin L.G., Camara A.K., Henry M.M., Stowe D.F. Attenuation of mitochondrial respiration by sevoflurane in isolated cardiac mitochondria is mediated in part by reactive oxygen species. Anesthesiology 2004, 100:498-505.
75. Marinovic J., Bosnjak Z.J., Stadnicka A. Distinct roles for sarcolemmal and mitochondrial adenosine triphosphate-sensitive potassium channels in isoflurane-induced protection against oxidative stress. Anesthesiology 2006, 105:98-104.
76. Kevin L.G., Novalija E., Stowe D.F. Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg 2005, 101:1275-1287.
77. Ljubkovic M., Mio Y., Marinovic J., et al. Isoflurane preconditioning uncouples mitochondria and protects against hypoxia-reoxygenation. Am J Physiol Cell Physiol 2007, 292:1583-1590.
78. Skulachev V.P. Uncoupling: new approaches to an old problem of bioenergetics. Biochim Biophys Acta 1998, 1363:100-124.
79. Jamnicki-Abegg M., Weihrauch D., Pagel P.S., et al. Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression. Anesthesiology 2005, 103:1006-1014.
80. Dirnagl U., Becker K., Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 2009, 8:398-412.
81. Hieber S., Huhn R., Hollmann M.W., Weber N.C., Preckel B. Hypoxia-inducible factor 1 and related gene products in anaesthetic-induced preconditioning. Eur J Anaesthesiol 2009, 26:201-206.
82. Zuurbier C.J., Smeele K.M.A., Eerbeek O. Mitochondrial hexokinase and cardioprotection of the intact heart. J Bioenerg Biomembr 2009, 41:181-185.
83. Lopez M.M., Kosk-Kosicka D. How do volatile anesthetics inhibit Ca2+-ATPases?. J Biol Chem 1995, 270:28239-28245.
84. Wang L., Ko K.W., Lucchinetti E., et al. Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift. Anesthesiology 2010, 113:541-551.
85. Forner F., Foster L.J., Campanaro S., Valle G., Mann M. Quantitative proteomic comparison of rat mitochondria from muscle, heart, and liver. Mol Cell Proteomics 2006, 5:608-619.
86. Bodyak N., Kang P.M., Hiromura M., et al. Gene expression profiling of the aging mouse cardiac myocytes. Nucleic Acids Res 2002, 30:3788-3794.
87. Lee C.K., Allison D.B., Brand J., Weindruch R., Prolla T.A. Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts. Proc Natl Acad Sci USA 2002, 99:14988-14993.
88. Sniecinski R., Liu H. Reduced efficacy of volatile anesthetic preconditioning with advanced age in isolated rat myocardium. Anesthesiology 2004, 100:589-597.
89. Wei H., Liang G., Yang H. Isoflurane preconditioning inhibited isoflurane-induced neurotoxicity. Neurosci Lett 2007, 425:59-62.
90. Klawitter J., Gottschalk S., Hainz C., Leibfritz D., Christians U., Serkova N.J. Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism. Chem Res Toxicol 2010, 23:608-619.
91. Lee J., Bruce-Keller A.J., Kruman Y., Chan S.L., Mattson M.P. 2-Deoxy-d-glucose protects hippocampal neurons against excitotoxic and oxidative injury: evidence for the involvement of stress proteins. J Neurosci Res 1999, 57:48-61.
92. Gáspár T., Kis B., Snipes J.A., et al. Transient glucose and amino acid deprivation induces delayed preconditioning in cultured rat cortical neurons. J Neurochem 2006, 98:555-565.
93. Puente E.C., Silverstein J., Bree A.J., et al. Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia. Diabetes 2010, 59:1055-1062.
94. Komatsu H., Nogaya J., Kuratani N., Ueki M., Yokono S., Ogli K. Psychomotor performance during initial stage of exposure to halothane, enflurane isoflurane and sevoflurane in mice. Clin Exp Pharmacol Physiol 1997, 24:706-709.
95. Rafalski V.A., Brunet A. Energy metabolism in adult neural stem cell fate. Prog Neurobiol 2011, 93:182-203.
96. Stratmann G., Sall J.W., May L.D., et al. Isoflurane differentially affects neurogenesis and long-term neurocognitive function in 60-day-old and 7-day-old rats. Anesthesiology 2009, 110:834-848.